These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17714081)

  • 1. 17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets.
    Chen L; Liu Y; Cui B; Mi Q; Huang Y; Fan L; Chen Q; Tang J; Ferro A; Ji Y
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):972-8. PubMed ID: 17714081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advanced glycation end products in vitro.
    Han Y; Liu Y; Mi Q; Xie L; Huang Y; Jiang Q; Chen Q; Ferro A; Liu N; Ji Y
    Int J Vitam Nutr Res; 2010 Jun; 80(3):168-77. PubMed ID: 21234858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human endothelial cell nitric oxide synthesis by advanced glycation end-products but not glucose: relevance to diabetes.
    Xu B; Ji Y; Yao K; Cao YX; Ferro A
    Clin Sci (Lond); 2005 Nov; 109(5):439-46. PubMed ID: 16022682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroepiandrosterone prevents the aggregation of platelets obtained from postmenopausal women with type 2 diabetes mellitus through the activation of the PKC/eNOS/NO pathway.
    Muñoz YC; Gomez GI; Moreno M; Solis CL; Valladares LE; Velarde V
    Horm Metab Res; 2012 Jul; 44(8):625-31. PubMed ID: 22517552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridoxine increases nitric oxide biosynthesis in human platelets.
    Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
    Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17Beta-oestradiol enhances nitric oxide synthase activity in endothelium-denuded rat aorta.
    Binko J; Murphy TV; Majewski H
    Clin Exp Pharmacol Physiol; 1998 Feb; 25(2):120-7. PubMed ID: 9493500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory signaling of 17β-estradiol in platelet activation: the pivotal role of cyclic AMP-mediated nitric oxide synthase activation.
    Wu GJ; Lee JJ; Chou DS; Jayakumar T; Hsiao G; Chen WF; Sheu JR
    Eur J Pharmacol; 2010 Dec; 649(1-3):140-9. PubMed ID: 20883689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity.
    O'Kane P; Xie L; Liu Z; Queen L; Jackson G; Ji Y; Ferro A
    Cardiovasc Res; 2009 Jul; 83(1):123-30. PubMed ID: 19377066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates.
    Goubareva I; Gkaliagkousi E; Shah A; Queen L; Ritter J; Ferro A
    Cardiovasc Res; 2007 Sep; 75(4):793-802. PubMed ID: 17572401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17beta-estradiol activates ICI 182,780-sensitive estrogen receptors and cyclic GMP-dependent thioredoxin expression for neuroprotection.
    Lee SY; Andoh T; Murphy DL; Chiueh CC
    FASEB J; 2003 May; 17(8):947-8. PubMed ID: 12626428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of endothelial nitric oxide synthase: involvement of protein kinase G 1 beta, serine 116 phosphorylation and lipid structures.
    John TA; Ibe BO; Raj JU
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):148-58. PubMed ID: 17892503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
    Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
    Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products.
    Xu B; Chibber R; Ruggiero D; Kohner E; Ritter J; Ferro A
    FASEB J; 2003 Jul; 17(10):1289-91. PubMed ID: 12738813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the L-arginine-NO-cGMP pathway in spontaneously hypertensive rat platelets: the effects of pregnancy.
    Ognibene DT; Moss MB; Matsuura C; Brunini TM; de Moura RS; Mendes-Ribeiro AC; Resende AC
    Hypertens Res; 2010 Sep; 33(9):899-904. PubMed ID: 20555333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of nitric oxide synthase activity in human platelets by nitroglycerin and authentic nitric oxide.
    Chen LY; Mehta JL
    J Investig Med; 1997 Feb; 45(2):69-74. PubMed ID: 9084577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased nitric oxide production in platelets from severe chronic renal failure patients.
    Siqueira MA; Brunini TM; Pereira NR; Martins MA; Moss MB; Santos SF; Lugon JR; Mendes-Ribeiro AC
    Can J Physiol Pharmacol; 2011 Feb; 89(2):97-102. PubMed ID: 21326340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calreticulin Transacetylase mediated activation of human platelet nitric oxide synthase by acetyl group donor compounds.
    Kumar A; Sushama A; Manral S; Sinha R; Joshi R; Singh U; Rohil V; Prasad AK; Parmar VS; Raj HG
    Nitric Oxide; 2012 Jan; 26(1):9-19. PubMed ID: 22100620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet nitric oxide signalling in heart failure: role of oxidative stress.
    Shah A; Passacquale G; Gkaliagkousi E; Ritter J; Ferro A
    Cardiovasc Res; 2011 Sep; 91(4):625-31. PubMed ID: 21502370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggregability in hypertension.
    de Meirelles LR; Mendes-Ribeiro AC; Santoro MM; Mendes MA; da Silva MN; Mann GE; Brunini TM
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1267-71. PubMed ID: 17973865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of advanced glycation end-products prevent loss of enteric neuronal nitric oxide synthase in diabetic rats.
    Jeyabal PV; Kumar R; Gangula PR; Micci MA; Pasricha PJ
    Neurogastroenterol Motil; 2008 Mar; 20(3):253-61. PubMed ID: 17971026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.